The Impact of Study Size on COVID‐19 Treatment Outcomes: A Meta‐Epidemiological Study Comparing Large and Small Randomized Controlled Trials
Reviews in Medical Virology · 2026-03 · 36 (2)
DOI: 10.1002/rmv.70125 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Reviews in Medical Virology, online erschienen am 07.03.2026. Verfasst von Dong Hyun Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, COVID-19, COVID-19 Drug Treatment, Antiviral Agents. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yonsei Fellowship.
Abstract (Originalsprache)
Small randomized controlled trials (RCTs) in COVID‐19 meta‐analyses have been associated with more favourable treatment effects and reduced result stability. This study assessed how trial size impacts effect estimates, statistical stability, and risk of bias. Following PRISMA guidelines, we identified meta‐analyses of COVID‐19 treatments included in WHO, NIH, and the LIVING Project. Trials were classified by log‐scale sample size, and separate pooled meta‐analyses were conducted for large‐only, small‐only, and combined trials. Comparative metrics included the Ratio of Odds Ratios (ROR), Kappa statistics, Fragility Index (FI), Reverse Fragility Index (RFI), and Cochrane Risk of Bias assessments. Sensitivity analyses applied alternative size thresholds (≥ 1000 participants and median‐based cutoffs) and stratified results by treatment and outcome type. Across 25 meta‐analyses including 221 RCTs (46 large, 175 small), small trials produced more extreme estimates in 19 analyses and wider confidence intervals in 23. The pooled ROR was 0.85 (95% CI: 0.76–0.95; P = 0.004), decreasing to 0.81 (95% CI: 0.68–0.95; P = 0.011) when limited to small trials published before the first large trial. RORs remained below 1 across treatment and outcome types. Agreement between small and large trials was minimal, while large trials showed substantial agreement with overall estimates. Stability and bias profiles favoured large trials (FI: 14.0 vs. 4.0; RFI: 10.0 vs. 5.0). In conclusion, small RCTs tend to overestimate treatment effects and yield less precise, less stable results. Meta‐analyses should prioritise large, high‐quality trials and interpret small‐study findings with caution, particularly in rapidly evolving research contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yonsei University College of Medicine, Seoul, Korea.
- Luton & Dunstable University Hospital, Bedfordshire Hospitals NHS Foundation Trust, Luton, UK.
- Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.
- Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
- Data Science, Evidence-Based and Clinical Research Laboratory, Department of Health, Social and Clinical Pharmacy, College of Pharmacy, Chung-Ang University, Seoul, Korea.
- Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
ORCID-Profile: Dong Hyun Kim, Michael Eisenhut, Eunyoung Kim, Justin Stebbing, Yonghong Peng, Jae Il Shin
Förderung
- Yonsei Fellowship
Zitieren
APA
Kim, D. H., Lim, S., Eisenhut, M., Kronbichler, A., Kim, E., Kim, M. S., Papatheodorou, S. I., Stebbing, J., Peng, Y., Oh, S. S., Shin, J. I., & Smith, L. (2026). The Impact of Study Size on COVID‐19 Treatment Outcomes: A Meta‐Epidemiological Study Comparing Large and Small Randomized Controlled Trials. Reviews in Medical Virology, 36(2). https://doi.org/10.1002/rmv.70125
Vancouver
Kim DH, Lim S, Eisenhut M, Kronbichler A, Kim E, Kim MS, et al. The Impact of Study Size on COVID‐19 Treatment Outcomes: A Meta‐Epidemiological Study Comparing Large and Small Randomized Controlled Trials. Reviews in Medical Virology. 2026;36(2). doi:10.1002/rmv.70125
BibTeX
@article{Kim2026,
author = {Kim, Dong Hyun and Lim, Soojin and Eisenhut, Michael and Kronbichler, Andreas and Kim, Eunyoung and Kim, Min Seo and Papatheodorou, Stefania I and Stebbing, Justin and Peng, Yonghong and Oh, Sarah Soyeon and Shin, Jae Il and Smith, Lee},
title = {The Impact of Study Size on COVID‐19 Treatment Outcomes: A Meta‐Epidemiological Study Comparing Large and Small Randomized Controlled Trials},
journal = {Reviews in Medical Virology},
year = {2026},
volume = {36},
number = {2},
doi = {10.1002/rmv.70125}
}
EUVIMED